Differences in megakaryocyte expansion potential between CD34+ stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children

Experimental Hematology

Volumn 28, Issue 9, 2000, Pages 1054-1061

  Van Den Oudenrijn, Sonja ^a   Von Dem Borne, Albert E G K ^a   De Haas, Masja ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow; Cord blood; Expansion; Megakaryocyte; Peripheral blood

Indexed keywords

CD34 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 3; THROMBOPOIETIN;

ADULT; ARTICLE; BLOOD; BLOOD AUTOTRANSFUSION; BONE MARROW CELL; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MONOCYTE; PLOIDY; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; TISSUE EXPANSION; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD34; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; CYTOKINES; FETAL BLOOD; HEMATOPOIESIS; HUMAN; IMMUNOPHENOTYPING; INTERLEUKIN-1; INTERLEUKIN-3; MEGAKARYOCYTES; PLOIDIES; STEM CELLS; THROMBOPOIETIN;

EID: 0033796946     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00517-8     Document Type: Article

References (40)

1. Korbling M., Fliedner T.M., Holle R.et al. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML. influence of source and cell composition of the autograft on hematopoietic reconstitution and disease-free survival Bone Marrow Transplant. 7:1991;343.
2. Przepiorka D., Anderlini P., Ippoliti C.et al. Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplant. 19:1997;455.
3. Bensinger W.I., Clift R., Martin P.et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies. a retrospective comparison with marrow transplantation Blood. 88:1996;2794.
4. Cairo M.S., Wagner J.E. Placental and/or umbilical cord blood. an alternative source of hematopoietic stem cells for transplantation Blood. 90:1997;4665.
5. +) stem cells in cord blood Blood. 88:1996;114a. (abstr).
6. Gluckman E., Rocha V., Boyer-Chammard A.et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med. 337:1997;373.
7. Shaw P.H., Haut P.R., Olzewski M., Kletzel M. Hematopoietic stem-cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome. one center's experience Pediatr Transplant. 3:1999;315.
8. Webb I.J., Anderson K.C. Risks, costs, and alternatives to platelet transfusions. Leuk Lymphoma. 34:1999;71.
9. Glaspy J., Vredenburgh J., Demeti G.D.et al. Effects of PEGylated recombinant human megakaryocyte growth and development factor before high-dose chemotherapy with peripheral blood progenitor cell support. Blood. 90:1997;580a. (abstr).
10. Bolwell B., Vredenburgh J., Overmoyer B.et al. Safety and biologic effect of PEGylated recombinant human megakaryocyte growth and development factor in breast cancer patients following autologous peripheral blood progenitor cell transplantation. Blood. 90:1997;171a. (abstr).
11. Linker C., Anderlini P., Herzig R.et al. A randomized, placebo-controlled, phase II trial of recombinant human thrombopoietin (rhTPO) in subjects udergoing high dose chemotherapy (HDC) and PBPC transplant. Blood. 92:1998;682a. (abstr).
12. Kuter D.J., Cebon J., Harker L.A., Petz L.D., McCullough J. Platelet growth factors. potential impact on transfusion medicine Transfusion. 39:1999;321.
13. Nash R.A., Kurzrock R., DiPersio J.et al. A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 6:2000;25.
14. Kaushansky K. Thrombopoietin. the primary regulator of platelet production Blood. 86:1995;419.
15. + cells measured under conditions that prevent P-selectin mediated binding of platelets. Blood. 86:1995;3771.
16. + cells best predict platelet recovery after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 21:1998;1217.
17. Bertolini F., Battaglia M., Pedrazzoli P.et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipient. Blood. 89:1997;2679.
18. van den Oudenrijn S., de Haas M., Calafat J., van der Schoot C.E., von dem Borne A.E.G.K. A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryoytes for transfusion purposes. Br J Haematol. 106:1999;553.
19. Debili N., Issaad C., Masse J.M.et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood. 80:1992;3022.
20. - cells in cord blood and bone marrow. Blood. 86:1995;3745.
21. + cells from neonatal blood in the presence of thrombopoietin, a comparison with cord blood and bone marrow. Bone Marrow Transplant. 24:1999;247.
22. Lefebvre P., Winter J.N., Kahn L.E., Giri J.G., Cohen I. Megakaryocyte ex vivo expansion potential of three hematopoietic sources in serum and serum-free medium. J Hematother. 8:1999;199.
23. + human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp Hematol. 26:1998;1034.
24. + purified cells from human cord blood and bone marrow. Stem Cells. 13:1995;281.
25. Wang J.C.Y., Doedens M., Dick J.E. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 89:1997;3919.
26. Guerriero R., Gabbianelli T.M., Mattia G.et al. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood. 86:1995;3725.
27. Debili N., Wendling F., Katz A.et al. The mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood. 86:1995;2516.
28. Hogge D., Fanning S., Bockhold K.et al. Quantitation and characterization of human megakaryocyte colony-forming cells using a standardized serum-free agarose assay. Br J Haematol. 96:1997;790.
29. Williams J.L., Pipia G.G., Datta N.S., Long M.W. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood. 91:1998;4118.
30. + progenitor cells from bone marrow and G-CSF mobilized peripheral blood Exp Hematol. 25:1997;1125.
31. - bone marrow cells with multilineage potential at the single-cell level. key role of thrombopoietin Blood. 90:1997;2282.
32. -) human bone marrow progenitor cells. Distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha. J Immunol. 158:1997;5169.
33. Choi E.S., Hokom M.M., Chen J.et al. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis. Br J Haematol. 95:1996;227.
34. + progenitor cells cultured in serum-depleted medium. Stem Cells. 15:1997;18.
35. Dolzhanskiy A., Basch R.S., Karpatkin S. The development of human megakaryocytes. III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3 Blood. 89:1997;426.
36. Dolzhanskiy A., Hirst J., Basch R.S., Karpatkin S. Complementary and antagonistic effects of IL-3 in the early development of human megakaryocytes in culture. Br J Haematol. 100:1998;415.
37. Hagiwara T., Kodama I., Horie K., Kato T., Miyazaki H. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin. Exp Hematol. 26:1998;228.
38. Tao H., Gaudry L., Rice A., Chong B. Cord blood is better than bone marrow for generating megakaryocytic progenitor cells. Exp Hematol. 27:1999;293.
39. Schipper L.F., Brand A., Reniers N.C., Melief C.J., Willemze R., Fibbe W.E. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood. Br J Haematol. 101:1998;425.
40. Tavassoli M. Megakaryocyte-platelet axis and the process of platelet formation and release. Blood. 55:1980;537.